RxEconomics Logo - Health Economics and Outcomes Research Consultancy specializing in AI-driven analytics

RxEconomics Solutions

RxEconomics is a boutique health economics and policy research firm providing advanced analytical solutions with a laser focus on creating value for our clients and delivering results with precision and speed. Led by Dr. M. Christopher Roebuck, who brings over 27 years of experience in health economics, our team combines deep expertise in econometrics and biostatistics with innovative AI tools to deliver insights quickly and cost-effectively.

As a nimble firm, we offer personalized, senior-level attention on every project – ensuring high-quality, actionable results in half the time of traditional approaches. Our solutions span four key service areas: AI-Driven Analytics & Real-World Evidence, Health Economics & Outcomes Research, Health Policy Analysis & Market Access, and Litigation Support & Expert Witness. Across all these domains, we leverage cutting-edge analytics (including machine learning and generative AI) to provide you with data-driven evidence that drives better decisions and tangible outcomes.

AI-Driven Analytics & Real-World Evidence

Real-World Evidence (RWE) is increasingly vital in healthcare decision-making, as it complements clinical trial data with insights from actual clinical practice. RWE draws on real-life data sources – such as insurance claims, electronic health records, patient registries, and wearables – to show how treatments perform in diverse populations and routine care settings. These real-world insights help stakeholders understand treatment effectiveness, safety, and value in the contexts that matter most to payers, providers, and patients.

RxEconomics specializes in turning vast real-world datasets into actionable insights. We aggregate and analyze data from across the healthcare system to answer your pressing questions: How are patients using your therapy day-to-day? What outcomes are being achieved outside of controlled trials? What factors drive costs and variability in care? Our AI-driven approach to RWE uses advanced machine learning algorithms to sift through complex, high-volume data and uncover meaningful patterns. Artificial intelligence can organize big data in ways that reveal new insights for improved healthcare decisions, and we harness that power to accelerate your real-world analyses.

For example, our machine learning models can identify predictors of hospital readmission or treatment non-response, enabling you to intervene early and improve outcomes. This means you get faster, more accurate answers from real-world data – often discovering trends that traditional analysis might miss – so you can make evidence-backed decisions with confidence and agility.

Services Include:

  • Real-world data analysis and evidence generation
  • Predictive modeling and risk stratification
  • Treatment pattern and medication adherence analysis
  • Comparative effectiveness research
  • Healthcare utilization and cost analysis
  • Patient-reported outcomes assessment
  • AI-powered data mining and pattern recognition

Health Economics & Outcomes Research

Health Economics & Outcomes Research is all about demonstrating the value of healthcare interventions through data-driven analysis. HEOR evaluates the costs, outcomes, and quality-of-life impacts of health treatments to help decision-makers understand which options deliver the best value for patients and health systems. In an era of value-based care and rising costs, robust HEOR is essential for proving the clinical and economic benefits of new therapies, programs, or policies.

RxEconomics delivers sophisticated HEOR studies that meet the highest methodological standards while maintaining practical relevance. We design and execute economic models, cost-effectiveness analyses, budget impact models, and outcomes studies that address your specific needs – whether you're seeking to demonstrate value to payers, inform pricing strategies, or guide healthcare resource allocation. Our team has extensive experience in both academic research and industry applications, ensuring that our analyses are both scientifically rigorous and commercially relevant.

We're known for our ability to translate complex economic concepts into clear, compelling value stories that resonate with diverse stakeholders. By combining advanced statistical techniques with deep therapeutic knowledge, we help you quantify and communicate the full value of your interventions – from clinical benefits and cost offsets to quality-of-life improvements and broader societal impacts.

Services Include:

  • Cost-effectiveness and cost-utility analyses
  • Budget impact modeling
  • Economic burden of illness studies
  • Plan design and optimization analyses
  • Quality of life and patient-reported outcomes research
  • Cost-of-care and resource utilization studies
  • Value dossier development

Health Policy Analysis & Market Access

Health Policy Analysis helps organizations navigate the complex and ever-changing landscape of healthcare regulations, laws, and reimbursement policies. Policy changes – from new legislation and government programs to updates in payer coverage criteria – can profoundly affect how healthcare is delivered and paid for. RxEconomics enables you to stay ahead of these changes by providing expert analysis and strategic guidance in a complex policy environment.

Our policy work combines rigorous economic analysis with practical insights into the healthcare system. We assess how policy changes might impact your organization, products, or services, and help you develop effective responses. Whether you're trying to understand the implications of a new value-based payment model, evaluate the potential effects of proposed legislation, or develop evidence to support coverage decisions, our team provides the analytical support and strategic guidance you need.

We also support market access strategies with targeted analyses that demonstrate value to payers and providers. By identifying the economic and clinical evidence most relevant to decision-makers, we help you develop compelling value propositions that address the specific needs and priorities of different stakeholders. Our work spans the entire product lifecycle, from early development planning to post-launch value demonstration.

Services Include:

  • Policy impact analysis and modeling
  • Reimbursement landscape assessment
  • Value proposition development
  • Payer evidence requirements analysis
  • Health technology assessment (HTA) support
  • Value-based contracting strategy
  • Regulatory and legislative monitoring

Litigation Support & Expert Witness

Litigation Support & Expert Witness Services from RxEconomics provide you with authoritative economic analysis and testimony in legal and regulatory disputes. In high-stakes healthcare cases – such as pharmaceutical litigation, insurance reimbursement disputes, or healthcare policy challenges – you need experts who can dissect complex economic issues and present findings clearly and credibly. We offer rigorous economic damages assessments, policy impact analyses, and expert testimony to support your case with data-driven evidence.

Dr. Roebuck brings extensive experience as an expert witness in healthcare economics, with a proven ability to explain complex concepts in accessible terms to judges, juries, and arbitrators. His academic credentials, industry experience, and publication record establish him as a credible authority in health economics, pharmaceutical policy, and healthcare analytics. Whether preparing expert reports, providing deposition testimony, or appearing in court, Dr. Roebuck delivers clear, compelling economic analyses that strengthen your legal position.

Our litigation support services extend beyond expert testimony to include economic modeling, damages calculations, and critical evaluation of opposing experts' methodologies. We work closely with legal teams to develop robust economic arguments grounded in sound theory and empirical evidence. Our analytical rigor and attention to detail ensure that our work withstands scrutiny and effectively advances your case.

Services Include:

  • Expert witness testimony
  • Economic damages assessment
  • Causal inference analysis
  • Rebuttal of opposing expert analyses
  • Healthcare market definition and competition analysis
  • Regulatory compliance economic assessment
  • Class certification analysis

Frequently Asked Questions

Our advanced analytics go beyond traditional methods—we leverage generative AI throughout our research and analytics workflow, including rapidly coding healthcare claims (HCPCS, CPT, ICD-10, NDC), developing intuitive model interfaces, enhancing data analysis, and significantly accelerating research synthesis and writing. This innovative approach reduces dataset preparation time, ensures exceptional accuracy, and allows us to deliver sophisticated predictive analyses and actionable insights far faster than traditional methods.

We utilize an extensive array of real-world data, including commercial insurance claims (e.g., MarketScan, Optum), Medicare Fee-for-Service, Medicare Advantage and Part D, Medicaid administrative data, electronic health records (EHR), patient registries, national surveys (such as MEPS and NHIS), and various public-use datasets. By integrating these diverse sources seamlessly, our analyses provide comprehensive, actionable insights tailored precisely to your strategic needs.

RxEconomics sets itself apart by uniquely blending advanced AI techniques with rigorous health economics methods, delivering meaningful insights—not just data. Our senior-level expertise, honed through decades of experience across pharmaceutical, payer, and policy sectors, ensures strategic precision. Unlike larger consultancies, you'll receive direct, expert-level guidance every step of the way, resulting in clearer answers, faster timelines, and measurable impact.

Our AI-enhanced approach typically delivers results in half the time compared to traditional consultancies. For example, a focused economic model might be completed in 4-6 weeks instead of 8-12 weeks, while comprehensive real-world evidence generation might require only 3-6 months rather than 6-12 months. Additionally, our efficiencies allow us to competitively price our projects, providing superior value while maintaining the highest quality standards.

Ready to Accelerate Your Health Economics Strategy?

Schedule your complimentary consultation to discover how RxEconomics delivers rapid analytics, credible real-world evidence, and strategic clarity.

Request Your Consult